OncoCyte OverviewOncoCyte EBIT
EBIT (Earnings Before Interest and Taxes) analysis for 0KCC.L.
Quarterly EBIT
-$10.33M
↓ 51.95% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$54.43M
↑ 7.2% YoY
Trailing 12 months ending Mar 31, 2026
OncoCyte OverviewEBIT (Earnings Before Interest and Taxes) analysis for 0KCC.L.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026